News & Events about Atricure Inc.
Ticker Report
2 months ago
Wesbanco Bank Inc. purchased a new position in AtriCure, Inc. (NASDAQ:ATRC Get Rating) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 6,525 shares of the medical device companys stock, ...
Ticker Report
2 months ago
StockNews.com started coverage on shares of AtriCure (NASDAQ:ATRC Get Rating) in a report published on Thursday morning. The firm issued a hold rating on the medical device companys stock. A number of other research analysts have also recently commented on the stock. BTIG Research cut...
Ticker Report
2 months ago
AtriCure, Inc. (NASDAQ:ATRC Get Rating) was the recipient of a significant growth in short interest in February. As of February 28th, there was short interest totalling 1,800,000 shares, a growth of 13.2% from the February 13th total of 1,590,000 shares. Based on an average daily volume of ...
Business Wire
3 months ago
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Oppenheimer 33rd Annual Healthcare Conference...
Business Wire
5 months ago
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference...